Production (Stage)
Perk Labs Inc.
PKLBF
$0.0001
$0.000.00%
OTC PK
| 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 125.00% | 99.54% | 6.67% | 5.65% | -60.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 125.00% | 99.54% | 6.67% | 5.65% | -60.83% |
| Cost of Revenue | 233.85% | 206.92% | 66.32% | -21.20% | -77.07% |
| Gross Profit | -57.69% | -59.09% | -60.00% | 453.85% | 322.86% |
| SG&A Expenses | -26.41% | -26.07% | -31.16% | -19.95% | -32.30% |
| Depreciation & Amortization | -35.16% | -19.61% | -12.89% | -5.41% | -4.35% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.25% | -31.90% | -33.60% | -22.02% | -22.56% |
| Operating Income | 32.73% | 33.15% | 33.91% | 22.27% | 21.83% |
| Income Before Tax | 49.46% | 44.38% | 19.42% | -131.21% | -72.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 49.46% | 44.38% | 19.42% | -131.21% | -72.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.46% | 44.38% | 19.42% | -131.21% | -72.18% |
| EBIT | 32.73% | 33.15% | 33.91% | 22.27% | 21.83% |
| EBITDA | 31.06% | 32.13% | 33.70% | 22.69% | 22.17% |
| EPS Basic | 68.35% | 56.14% | 25.44% | -138.10% | -54.90% |
| Normalized Basic EPS | 59.74% | 50.62% | 39.76% | 30.11% | 28.04% |
| EPS Diluted | 52.02% | 50.23% | 20.55% | -75.22% | -13.82% |
| Normalized Diluted EPS | 61.33% | 50.63% | 39.51% | 30.00% | 27.88% |
| Average Basic Shares Outstanding | 64.49% | 37.65% | 10.18% | 10.44% | 13.05% |
| Average Diluted Shares Outstanding | 72.55% | 39.42% | 8.64% | 10.26% | 12.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |